Carcinoma, Islet Cell - 21 Studies Found Completed : Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma : Metastatic Gastrointestinal Carcinoid Tumor Pulmonary Carcinoid Tumor Drug: temsirolimus Given IV Completed : Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors : Gastrointestinal Carcinoid Tumor Islet Cell Tumor Lung Can : 2001-12-07 : Drug: thalidomide Completed : Clinical Evaluation of i-STAT Analyzer : Diabetes Mellitus Neonatal Hypoglycemia Pancreatic : 2016-07-06 Active, not recruiting : Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery : Pancreatic Gastrinoma Pancreatic Neuroendocrine Tumor G1 P : 2010-10-27 : Biological: Bevacizumab Given Active, not recruiting : Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors : Gastrinoma Glucagonoma Insulinoma Drug: temozolomide Given PO Withdrawn : Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors : Gastrinoma Glucagonoma Insulinoma Drug: dovitinib lactate Given Terminated : Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery : Gastrinoma Glucagonoma Insulinoma Drug: everolimus Given PO Active, not recruiting : Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors : Gastrinoma Glucagonoma Insulinoma Drug: capecitabine Given PO Completed : Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors : Gastrinoma Glucagonoma Insulinoma Drug: regorafenib Given PO Completed : Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors : Gastrinoma Glucagonoma Insulinoma
